Antimicrobial Resistance Pattern of Gram-negative Bacteria Causing Urinary Tract Infection
AbstractUrinary tract infection (UTI) is a common and occasional recurrent bacterial illness with an increasing resistance to antimicrobials. Antibiotic resistance in UTI is a growing public health problem in the world including Bangladesh. The study objective was to examine the present incidence of UTIs in Bangladesh in a point period of time from January to December 2007. A retrospective data analysis of culture results of urinary pathogens was performed. The data was collected from the Clinical Microbiology Laboratory of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). The data included culture results of 9,854 urine samples and only Gram-negative isolates irrespective of age groups were analyzed. The prevalence of UTI was observed in 24.14%. It was observed that out of 2,379 uropathogens Escherichia coli (66.92%) was the most prevalent isolate followed by Klebsiella spp. (13.45%), Proteus spp. (6.77%) and Pseudomonas spp. (6.77%). The percentage of resistance to different antibiotics was higher in E. coli, Klebsiella spp. and Pseudomonas spp. isolates compared to that of others. Among the total number of isolates the resistant rate of E. coli and Klebsiella spp. to ampicillin was 86.09% and 83.33% and to cotrimoxazole was 67.61% and 59.81%, their resistance rate to nalidixic acid was 83.28% and 61.54%. All other isolates also showed above 80% resistance to ampicillin and above 50% to cotrimoxazole whereas imipenem was found to be the most effective against the uropathogens followed by amikacin.
Key Words: Urinary tract infection; Antimicrobial resistance; Uropathogens; Bacteriuria; Gram-negative bacteria
Stamford Journal of Pharmaceutical Sciences Vol.2(1) 2009: 44-50
Each author must agree to this statement
Authorship: This manuscript is the original work of the authors, each of whom has read and approved of the work. Each author satisfied the requirements contained in 'Author Guidelines' having participated sufficiently in the work to take public responsibility for the content. This participation includes:
- Conception or design of the study, or analysis and interpretation of data, or both
- Drafting the article or revising it for critically important intellectual content
- Approval of the final 'to be published' version
All authors must take responsibility for the integrity of the work. Participating solely in the collection of data does not justify authorship.
Prior publication: This work is not currently under consideration by any other journal. Information about prior publication of any part of this work, or inclusion of patients detailed herein in any other work, has been provided in the cover letter.
Conflict of interest: Details of any financial or other relationship between any author and any other party that may lead to a conflict of interest with the subject or any materials mentioned in this article have been disclosed in the cover letter.